Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease neuropathy, peripheral
Comorbidity C0007113|rectal cancer
Sentences 7
PubMedID- 22496202 The present study investigated the occurrence of subclinical peripheral neuropathy in patients with colorectal cancer before the initiation of chemotherapy.
PubMedID- 25627820 We therefore conducted a multicenter randomized phase iii trial to compare fluorouracil, leucovorin, and oxaliplatin (mfolfox6) with and without goshajinkigan (gjg), a traditional japanese herbal medicine (kampo), to determine gjg's potential for reducing peripheral neuropathy in patients with colorectal cancer.
PubMedID- 21444285 peripheral neuropathy in patients with colorectal cancer receiving oxaliplatin.
PubMedID- 25183707 A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy.
PubMedID- 24122404 A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer.
PubMedID- 25417732 peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration.
PubMedID- 22865779 Background: to report our prospective experience on the incidence and pattern of oxaliplatin (oxa)-induced peripheral neuropathy (oxa-ipn) in patients with colorectal cancer (crc) treated with either folfox-4 or xeloda + oxaliplatin (xelox).

Page: 1